Ligand validation:6FXK

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FXK_NAG_A_805	10%	88%	0.16	0.661	0.22	0.43	-	-	1	0	100%	1
6FXX_NAG_A_810	26%	87%	0.109	0.745	0.24	0.44	-	-	0	0	100%	1
6TEZ_NAG_A_808	20%	72%	0.209	0.813	0.43	0.66	-	1	0	0	100%	1
6TEU_NAG_A_807	17%	70%	0.097	0.672	0.5	0.65	-	1	1	0	100%	1
6FXT_NAG_A_808	17%	82%	0.138	0.709	0.27	0.52	-	-	0	0	100%	1
8ONE_NAG_A_1005	16%	84%	0.19	0.756	0.28	0.48	-	-	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.